Drug discovery--an operating model for a new era
Article Abstract:
Drug developers will have to implement major reforms in order to retain their innovative and competitive levels. New sciences, technologies, and organizational tools have created newfound opportunities and challenges for drug discovery companies.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
EU's new orphan drug regulations
Article Abstract:
The European Commission approved the creation of the Orphan Medicinal Products to assess a drug for orphan status before being submitted to the European Medicines Evaluation Agency.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Drug approval in Europe
Article Abstract:
The European Medicines Evaluation Agency was created by the European Commission to manage the drug approval process in Europe.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: London Forfaiting: deferral gains. Man Group. Provident Financial
- Abstracts: Banking on reform. Eastern promise. An economic Eden?
- Abstracts: Carrier firepower: realizing the potential. Naval Hawks bring new capabilities
- Abstracts: Generation of a synthetic lymphoid tissue-like organoid in mice. Efficient generation of human T cells from a tissue-engineered thymic organoid
- Abstracts: Human fly bites rub Celera. So many genomes, so little time. India sequences chickpea